Science Marches On and Policy Lags Behind

Andrew L. Pecora, MD
Published: Sunday, May 07, 2017
Andrew L. Pecora, MD

Andrew L. Pecora, MD

In April, I prepared to attend the 2017 American Association of Cancer Research (AACR) meeting expecting that the breakthrough discoveries presented would offer my patients greater hope to defeat the dreaded disease we call cancer. I was not disappointed. The research presented at AACR focused on the fundamentals of cell biology, cell aging, and cell death; how the immune system recognizes and kills cancer cells; and how, in turn, cancer cells avoid immune system detection. It is easy to understand how the body of this research will apply to and benefit other aspects of medicine, such as aging, diabetes, rheumatologic disorders, inflammatory bowel disease, infectious diseases, and neurodegenerative diseases.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication